• Mi Re-Unir
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Buscar 
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Buscar
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Buscar

    Buscar

    Mostrar filtros avanzadosOcultar filtros avanzados

    Filtros

    Use filtros para refinar sus resultados.

    Mostrando ítems 31-40 de 75

    • Opciones de clasificación:
    • Relevancia
    • Título Asc
    • Título Desc
    • Fecha Asc
    • Fecha Desc
    • Fecha Publicación Asc
    • Fecha Publicación Desc
    • Resultados por página:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100

    HTLV-1 infection and health outcomes 

    Ramos, José M.; Mendoza, Carmen de; Soriano, Vicente (1) (The Lancet Infectious Diseases, 2020-04)
    The meta-analysis published by Gill Schierhout and colleagues1 reported an increased relative risk of premature death in individuals infected with HTLV-1 compared with individuals not infected with HTLV-1 (RR 1·57, 95% CI ...

    Hepatitis Delta Estimates in the United States Revisited 

    Soriano, Vicente (1); Gómez-Gallego, Felix (1); Corral, Octavio Jorge (1) (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019-10-30)
    To the Editor—We read with interest the article by Patel and colleagues [1], which reported an unexpected 33% prevalence of anti–hepatitis delta virus antibodies (anti-HDV-Abs) in a large and representative US household ...

    Tough requirements for new antiretroviral drugs 

    Mendoza, Carmen de; Soriano, Vicente (1) (The Lancet HIV, 2020-03)
    Medical and social attention to HIV infection has declined globally and is increasingly focused on developing regions, where the epidemic is still largely uncontrolled. In North America and western Europe, AIDS is rarely ...

    HTLV testing of solid organ transplant donors 

    Mendoza, Carmen de; Roc, Lourdes; Fernández-Alonso, Miriam; Soriano, Vicente (1) (Clinical Transplantation, 2019)
    Carta al editor

    Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2 

    Tzou, Philip L.; Descamps, Diáne; Rhee, Soo-Yon; Raugi, Dana N; Charpentier, Charlotte; Taveira, Nuno; Smith, Robert A; Soriano, Vicente (1); Mendoza, Carmen de; Holmes, Susan; Gottlieb, Geoffrey S.; Shafer, Robert W. (Journal of Infectious Diseases, 2020-06)
    Background: HIV-1 and HIV-2 differ in their antiretroviral (ARV) susceptibilities and drug resistance mutations (DRMs). Methods: We analyzed published HIV-2 pol sequences to identify HIV-2 treatment-selected mutations ...

    Hospital admissions in individuals with HTLV-1 infection in Spain 

    Ramos, José M.; Mendoza, Carmen de; Aguilera, Antonio; Barreiro, Pablo; Benito, Rafael; Eirós, José M.; Soriano, Vicente (1) (AIDS, 2020-06)
    OBJECTIVE: To examine the clinical burden and disease spectrum, as well as time trends for human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital admissions. DESIGN: Retrospective, observational study ...

    Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity 

    Guallar, María Pilar; Meiriño, Rosa; Donat-Vargas, Carolina; Jouvé, Nicolás; Soriano, Vicente (1) (International Journal of Infectious Diseases, 2020-08)
    A relationship between the infecting dose and the risk of disease severity has not been demonstrated for SARS-CoV-2 infection. Here, we report three clusters of individuals that were potentially exposed to distinct inoculum ...

    Long-acting antiretroviral therapy 

    Soriano, Vicente (1); Barreiro, Pablo; Mendoza, Carmen de (Nature Materials, 2020-08-01)
    Nanoformulations of cabotegravir prodrugs have been developed to prolong the pharmacokinetics of the antiretroviral agent. They can be present in the plasma of mice and non-human primates for a year following a single injection.

    Advances in hepatitis B therapeutics 

    Soriano, Vicente (1); Barreiro, Pablo; Cachay, Edward R.; Kottilil, Shyamasundaran; Fernandez-Montero, José V.; Mendoza, Carmen de (Therapeutic Advances in Infectious Disease, 2020-10)
    Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million people are chronically infected with the hepatitis B virus (HBV). Globally, chronic hepatitis B is the leading cause of ...

    Overt and occult hepatitis B among immigrants and native blood donors in Madrid, Spain 

    González, Rocío; Barea, Luisa; Arruga, Ana; Richart, Alberto; Soriano, Vicente (1) (Therapeutic Advances in Infectious Disease, 2020-12)
    Background: The risk of transfusion-transmitted viral infections is very low in developed countries. Recent massive migration flows from highly hepatitis B virus (HBV), hepatitis C virus (HCV) and/or HIV endemic regions ...
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • . . .
    • 8

    Mi cuenta

    AccederRegistrar

    ¿necesitas ayuda?

    Manual de UsuarioAutorización TFG-M

    Listar

    todo Re-UnirComunidades y coleccionesPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de accesoEsta comunidadPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de acceso

    afina tu búsqueda

    Autor
    Soriano, Vicente (1) (75)
    Mendoza, Carmen de (21)Barreiro, Pablo (17)Corral, Octavio Jorge (1) (14)de Mendoza, Carmen (14)... ver todoPalabra claveScopus (59)JCR (47)Scopus(2) (10)HIV (9)COVID-19 (7)... ver todoFecha2022 (6)2021 (21)2020 (21)2019 (18)2018 (9)






    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja
     
    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja